Author | Thierry M. Jahan, MD | OncLive

Author | Thierry M. Jahan, MD


Dr. Thierry Jahan on the CRS-207 Vaccine in Mesothelioma

July 07, 2016


​Thierry M. Jahan, MD, a clinical professor in the Department of Medicine at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center, discusses a phase Ib trial of CRS-207 in malignant pleural mesothelioma (MPM).